Monday, April 15, 2024 12:45:17 PM
If we take a look at what I believe would be the worst case scenario, manually let's allow 200 hours to make it, that's every hour for over 8 days. Now lets say that every hour during this time a lab clinician has to be working on only that one batch of vaccine. I frankly don't know, but is $100 an hour a fair price for such people, if so we're saying it would take $20K in labor for the one batch. This would be over the cost of making it with the EDEN charging nothing for making it that way.
In reality I believe that one person can probably work with at least two different batches of vaccine, and perhaps several more, I'd like to hear others thought on this, but if we said two, it would bring the added cost to $10K per batch. I believe that NWBO would be in a position to negotiate for what will be charged for DCVax-L without consideration of how it's made. I would hope that the initial cost would be greater, to fully pay for manufacturing cost, and make a small profit, then so much more for each distributed vial of the vaccine.
Feel free to counter my argument, as well as my thinking on prices, but I think the company would be in a stronger position to say this is what we want to be paid, and how we want to be paid, regardless of how the vaccine was actually being manufactured. I also realize the cost of making and operating multiple tiny cleanrooms is far greater than one larger cleanroom, but understand that even in a small cleanroom, a few devices something like baby incubators with gloves that permit access to the media can be utilized so a single person should be able to work without the problems of going between cleanrooms, so productivity can be increased and cost reduced. Just think about it, I don't believe they'll push different prices for different manufacturing. The regulators will want the EDEN to meet capacity requirements, they don't need to be pushed for lower prices.
Gary
Recent NWBO News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM